Home > Boards > US Listed > Biotechs > Aerie Pharmaceuticals Inc. (AERI)

Aeri flying. Data so good no need for

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Johnny_C Member Profile
 
Followed By 27
Posts 11,312
Boards Moderated 0
Alias Born 04/20/16
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 5/25/2021 6:33:29 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/24/2021 5:26:40 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/12/2021 6:38:15 AM
Aerie Pharmaceuticals to Participate in the Bank of America Securities 2021 Healthcare Conference Business Wire - 5/6/2021 7:30:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/6/2021 6:11:26 AM
Aerie Pharmaceuticals EPS misses by $0.04, misses on revenue Seeking Alpha - 5/5/2021 4:07:39 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/5/2021 4:04:52 PM
Aerie Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Business Update Business Wire - 5/5/2021 4:01:00 PM
Aerie Pharmaceuticals Completes Enrollment of its Phase 2b Clinical Trial of AR-15512 (TRPM8 Agonist) Ophthalmic Solution for... Business Wire - 4/29/2021 6:30:00 AM
Aerie Pharmaceuticals to Announce First Quarter 2021 Financial Results and Host Conference Call on Wednesday, May 5, 2021 Business Wire - 4/28/2021 7:30:00 AM
Aerie Pharmaceuticals Announces Presentations at the 2021 Association for Research in Vision & Ophthalmology (ARVO) Annual Me... Business Wire - 4/28/2021 6:30:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 4/27/2021 4:17:40 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/27/2021 4:13:00 PM
Aerie Pharmaceuticals Receives Marketing Authorisation of Roclanda® 50 micrograms/ml + 200 micrograms/ml Eye Drops, Solution... Business Wire - 4/19/2021 6:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/14/2021 6:32:35 AM
Aerie Pharmaceuticals to Participate in the 20th Annual Needham Virtual Healthcare Conference Business Wire - 4/7/2021 7:30:00 AM
Aerie Pharmaceuticals Announces Publication of Peer-Reviewed Paper Evaluating the Treatment Effect of Netarsudil on Outflow F... Business Wire - 3/30/2021 8:05:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/11/2021 4:04:33 PM
Aerie Pharmaceuticals Announces Presentation at the Ophthalmology Innovation Summit Dry Eye Innovation Showcase Business Wire - 3/11/2021 4:01:00 PM
Aerie Pharmaceuticals to Participate in the Oppenheimer 31st Annual Virtual Healthcare Conference Business Wire - 3/11/2021 7:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/10/2021 6:31:58 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/1/2021 6:41:39 AM
Aerie Pharma’s Quarterly Sales Top Analysts’ Estimates; Shares Spike 16% TipRanks - 2/28/2021 4:16:58 AM
Aerie Pharmaceuticals shares rise after Q4 topline beat Seeking Alpha - 2/26/2021 10:40:35 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/25/2021 6:25:37 PM
Johnny_C   Wednesday, 10/11/17 09:31:01 AM
Re: Johnny_C post# 125
Post # of 156 
Aeri flying. Data so good no need for fda review friday

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences